Predictors of survival in gastric mucosa-associated lymphoid tissue lymphoma: An updated surveillance, epidemiology, and end results-based analysis of age and gender disparities

Table 2 Crude analysis of factors associated with all-cause mortality and cancer related mortality among United States patients diagnosed with mucosa-associated lymphoid tissue lymphoma between 2010 and 2021

Characteristics	Overall mortality. Crude proportional. Hazard ratio (95%CI)	Cancer related mortality. Crude proportional. Hazard ratio (95%CI)
Race
NH-White	1 (reference)	1 (reference)
NH-Black	1.16 (0.90-1.50)	1.43 (0.85-2.40)
Hispanic	0.80 (0.61-1.05)	1.12 (0.66-1.91)
Other	0.65 (0.46-0.92)	1.62 (0.96-2.72)
Gender
Female	1 (reference)	1 (reference)
Male	1.30 (1.09-1.54)b	1.29 (0.90-1.85)
Age at diagnosis (years)
0-39	1 (reference)	1 (reference)
40-59	1.01 (0.50-2.02)	1.10 (0.25-4.80)
60-79	2.34 (1.21-4.55)a	2.55 (0.62-10.43)
80+	8.04 (4.12-15.71)b	7.64 (1.85-31.61)b
Marital status
Married	1 (reference)	1 (reference)
Single	1.39 (1.09-1.77)b	1.59 (1.00-2.52)
Divorced/separated	1.85 (1.41-2.43)b	1.43 (0.78-2.60)
Widowed	2.80 (2.26-3.49)b	2.03 (1.25-3.28)b
Tumor stage
Localized	1 (reference)	1 (reference)
Regional	1.07 (0.80-1.43)	2.29 (1.38-3.82)b
Distant	1.78 (1.38-2.29)b	5.25 (3.50-7.88)b
Living area
Counties in metropolitan areas of 1 million persons	1 (reference)	1 (reference)
Counties in metropolitan areas of 250000 to 1 million persons	1.17 (0.95-1.44)	0.86 (0.55-1.35)
Counties in metropolitan areas of 250000 persons	1.23 (0.89-1.70)	0.56 (0.23-1.38)
Nonmetropolitan counties adjacent to a metropolitan area	1.01 (0.68-1.53)	0.91 (0.40-2.09)
Nonmetropolitan counties not adjacent to a metropolitan area	1.10 (0.72-1.68)	0.71 (0.26-1.94)
Income per year
< $40000	1 (reference)	1 (reference)
$40000-59999	0.59 (0.34-1.02)	0.55 (0.16-1.88)
$60000-79999	0.51 (0.30-0.86)a	0.60 (0.19-1.93)
$80000-99999	0.46 (0.27-0.78)b	0.57 (0.18-1.87)
$100000+	0.43 (0.25-0.75)b	0.64 (0.19-2.14)
Radiation
No	1 (reference)	1 (reference)
Yes	0.69 (0.58-0.83)b	0.54 (0.37-0.79)b
Chemotherapy
No	1 (reference)	1 (reference)
Yes	1.26 (1.01-1.59)a	2.76 (1.87-4.08)b
Surgery
No	1 (reference)	1 (reference)
Yes	1.22 (0.61-2.46)	1.04 (0.26-4.22)

^aP < 0.05.

^bP < 0.01.